Product Description
Brand Boditech
Sample Type Serum/ Plasma/ WB
Pack Size 24T
CAT No SMFP-2
Biomarker Cardiac
The appearance of elevated CK-MB levels in serum is highly specific and sensitive for myocardial cell wall injury. Since it varies from one to another, other biomarkers such as Troponin I should be considered together with the CK-MB test to assess heart health. It provides solution to measure blood CK-MB level on a POC level.
Rapid and Accurate CK-MB AssessmentWith advanced lateral flow immunoassay technology, the Boditech AFIAS CK-MB Analyzer delivers fast and dependable results for CK-MB enzyme levels. Suitable for whole blood, serum, or plasma samples, it produces results in just 10-15 minutes, ensuring timely patient assessment in urgent clinical situations. The analyzer is highly accurate and designed for efficient workflow.
Automated Operation and User-Friendly DesignThis equipment offers fully automatic operation with on-board calibration, an LCD touchscreen interface, and easy-to-follow instructions-making it ideal for busy clinical labs, hospitals, and point-of-care environments. Its built-in thermal printer and multiple data output options streamline reporting and connectivity, while internal and external quality control help maintain reliability.
Portable, Reliable, and CompliantWeighing only 2.2 kg and powered by a universal AC adapter, the AFIAS CK-MB is highly portable and effortless to set up. The kit is CE marked and ISO 13485 certified, ensuring compliance with international quality standards. Its robust design, long shelf life, and low noise operation guarantee consistent performance and peace of mind for professional users.
FAQ's of Boditech AFIAS Creatine Kinase Muscle Brain (CK-MB):
Q: How does the Boditech AFIAS CK-MB Analyzer process CK-MB measurement?
A: The analyzer uses advanced lateral flow immunoassay technology to quantitatively detect CK-MB levels in whole blood, serum, or plasma samples. The automatic calibration and real-time operation ensure accurate results within 10-15 minutes per test.
Q: What are the sample types compatible with the AFIAS CK-MB Analyzer?
A: The system is versatile and supports whole blood, serum, and plasma samples for the measurement of CK-MB enzyme activity, making it suitable for a variety of clinical and point-of-care settings.
Q: When should the AFIAS CK-MB Analyzer be used?
A: This analyzer is intended for professional use in clinical laboratories, hospitals, and point-of-care testing to quickly assess CK-MB levels, aiding in the diagnosis and management of muscle and brain tissue injury, especially in emergency settings.
Q: Where is this analyzer typically used?
A: The AFIAS CK-MB Analyzer is ideal for use in hospitals, clinics, clinical laboratories, and point-of-care environments where rapid and accurate CK-MB assessment is critical for patient care.
Q: What are the benefits of using this CK-MB Analyzer?
A: Key benefits include rapid and precise quantification of CK-MB (3-80 ng/mL), automated and user-friendly operation, built-in quality control, portable design, and compliance with CE and ISO 13485 standards, ensuring reliability and ease of use.
Q: How should the test kits be stored to maintain validity?
A: Kits should be stored at 2C to 8C and protected from light. Following these instructions helps preserve the reagents' activity and ensures reliable results within the 18-month shelf life.